Genetic Mobility and Instability of Retroviral Vector in Vector Producer Cells for Gene Therapy Won-Bin Young Iowa State University

Total Page:16

File Type:pdf, Size:1020Kb

Genetic Mobility and Instability of Retroviral Vector in Vector Producer Cells for Gene Therapy Won-Bin Young Iowa State University Iowa State University Capstones, Theses and Retrospective Theses and Dissertations Dissertations 1999 Genetic mobility and instability of retroviral vector in vector producer cells for gene therapy Won-Bin Young Iowa State University Follow this and additional works at: https://lib.dr.iastate.edu/rtd Part of the Genetics Commons, Microbiology Commons, and the Molecular Biology Commons Recommended Citation Young, Won-Bin, "Genetic mobility and instability of retroviral vector in vector producer cells for gene therapy" (1999). Retrospective Theses and Dissertations. 12196. https://lib.dr.iastate.edu/rtd/12196 This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital Repository. It has been accepted for inclusion in Retrospective Theses and Dissertations by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. INFORMATION TO USERS This manuscript has been reproduced from the microfilm master. UMI films the text directly from the original or copy submitted. Thus, some thesis and dissertation copies are in typewriter face, while others may be from any type of computer printer. The quality of this reproduction is dependent upon the quality of the copy submitted. Broken or indistinct print, colored or poor quality illustrations and photographs, print bleedthrough, substandard margins, and improper alignment can adversely affect reproduction. In the unlikely event that the author did not send UMI a complete manuscript and there are missing pages, these will be noted. Also, if unauthorized copyright material had to be removed, a note will indicate the deletion. Oversize materials (e.g., maps, drawings, charts) are reproduced by sectioning the original, beginning at the upper left-hand comer and continuing from left to right in equal sections with small overlaps. Each original is also photographed in one exposure and is included in reduced form at the back of the book. Photographs included in the original manuscript have been reproduced xerographically in this copy. Higher quality 6" x 9" black and white photographic prints are available for any photographs or illustrations appearing in this copy for an additional charge. Contact UMI directly to order. Bell & Howell Information and Leaming 300 North Zeeb Road, Ann ArtDor, Ml 48106-1346 USA 800-521-0600 Genetic mobility and instability of retroviral vector in vector producer cells for gene therapy by Won-BIn Young A dissertation submitted to the graduate faculty In partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY Co-majors: Molecular, Cellular and Developmental Biology: Nutritional Physiology Major Professors: Gary L. Lindberg and Charles J. Link, Jr. Iowa State University Ames, Iowa 1999 Copyright © Won-Bin Young, 1999. All rights reserved. DMI Number: 9941786 Copyright 1999 by- Young, Won-Bin All rights reserved. UMI Microform 9941786 Copyright 1999, by UMI Company. All rights reserved. This microform edition is protected against unauthorized copying under Title 17, United States Code. tnvn 300 North Zeeb Road Ann Arbor, MI 48103 ii Graduate College Iowa State University This is to certify that the Doctoral dissertation of Won-Bin Young has met the dissertation requirements of Iowa State University Signature was redacted for privacy. CD Major Professor Signature was redacted for privacy. o Majc^ Professor Signature was redacted for privacy. Signature was redacted for privacy. Signature was redacted for privacy. For the Graduate College iii TABLE OF CONTENTS LIST OF FIGURES v LIST OF TABLES vil ABSTRACT vlii CHAPTER 1. GENERAL INTRODUCTION 1 Introduction 1 Dissertation Organization 11 References 12 CHAPTER 2. RESTRICTION MAPPING OF RETROVIRAL VECTOR MUTATION BY ANALYZING EPISOMAL DNA 19 Introduction 20 Materials and Methods 21 Results 22 Discussion 24 References 24 CHAPTER 3. DNA METHYLATION INCREASES GENETIC INSTABILITY OF RETROVIRAL VECTOR PRODUCER CELLS 33 Abstract 34 Introduction 34 Materials and Methods 37 Results 40 Discussion 48 Acknowledgements 53 References 54 iv CHAPTER 4. CHIMERIC RETROVIRAL HELPER VIRUS AND PICORNAVIRUS IRES SEQUENCE TO ELIMINATE DNA METHYLATION FOR IMPROVED PACKAGING CELLS 80 Abstract 81 Introduction 82 Materials and Methods 84 Results 87 Discussion 92 Acknowledgements 94 References 94 CHAPTER 5. HIGH FREQUENCY RETROTRANSPOSITION OF RETROVIRAL VECTOR IN CULTURED VECTOR PRODUCER CELLS 114 Abstract 115 Introduction 116 Materials and Methods 118 Results 121 Discussion 126 Acknowledgements 128 References 129 CHAPTER 6. GENERAL CONCLUSIONS 142 References 148 APPENDIX A. HUMAN RETROVIRAL PACKAGING CELLS BASED ON A CHIMERIC HELPER VIRUS FOR HIGH VECTOR PRODUCTION 151 ACKNOWLEDGEMENTS 154 V LIST OF FIGURES CHAPTER 1 Figure 1. Retrovlrus-mediated gene transfer 2 Figure 2. Reverse transcription and recombination 4 Figure 3. Endogenous reverse transcriptase activity and retroelements 6 Figure 4. Env-receptor interference and superinfection of vectors on vector producer cells 8 Figure 5. Intracellular retrotransposition of an Env-defective Moloney murine leukemia virus 9 CHAPTER 2 Figure 1. Detection of second vector from LTKOSN.2 vector production 28 Figure 2. Location of episomal DNA in vector producer cells 30 Figure 3. Characterization of HSVtk deleted LTKOSN (ALTKOSN) by episomal DNA restriction mapping 32 CHAPTER 3 Figure 1. Increased copy number of LTKOSN and ALTKOSN is observed in LTKOSN.2 subclones 64 Figure 2. Genetic instability of integrated LTKOSN in VPC genome 66 Figure 3. Differential gene expressions of vectors and helper virus in LTKOSN.2 VPC subclones 68 Figure 4. Superinfection susceptibility of LTKOSN.2 VPC subclones 70 Figure 5. DNA methylation statuses of helper virus and vectors 72 Figure 6. Treatment with 5-aza-C partly restores the vector production ability in subclones 73 Figure 7. Treatment with 5-aza-C reverses the DNA methylation of helper virus 75 Figure 8. Increased DNA methylation in helper virus of subclone #4 over time 77 vi Figure 9. Transcription activity of fielper virus and retroviral vectors in LTK0SN.2 VPC subclone #4 79 CHAPTER4 Figure 1. Construction and cap-independent translation mechanism of chimeric pAM3-iRES-Zeo helper virus 103 Figure 2. Gene expression of pAM3-IRES-Zeo and vectors in LTK0SN.2 VPC subclones 105 Figure 3. DNA methylation of helper virus 5' LTR over time with and without Zeocin™ selection 107 Figure 4. The effectiveness of Zeocin selection on helper virus gene expression in AM IZ cells over time 109 Figure 5. Gene expression of pAM3-IRES-Zeo helper virus and LEIN vector in AMIZ cells transfected with LEIN vector 111 Figure 6. Drug selection eliminates DNA methylation of helper virus and vector from VPC population 113 CHAPTER 5 Figure 1. Retrotransposition assay with pELNIH vector 137 Figure 2. Retrotransposed ELNIH vector integrated into different chromosomal locations 139 Figure 3. Scheme of serial deletion constructs of MoMLV 141 CHAPTER 6 Figure 1. Scheme of cascade reactions initiated by increased DNA methylation of helper virus 5' LTR 144 Figure 2. Alternative pathway of retroviral replication 147 APPENDIX A Figure 1. Variable sensitivity to human serum of vectors produced from different packaging cells 153 VII LIST OF TABLES CHAPTER 3 Table 1. Titer of LTKOSN.2 sub-clones treated with 5-aza-C 62 Table 2. Decreased titer of LTKOSN.2 VPC subclone #4 in continuous cell culture 62 CHAPTER 4. Table 1. Titer of LTKOSN.2 VPC subclones before and after transfection of pAM3-IRES-Zeo helper virus 101 Table 2. Increased resistance of superinfection by Zeocin™ selection 101 Table 3. Titer of AMIZ cells transfected with LEIN vector with continuous drug selection 101 CHAPTER 5. Table 1. Retrotransposition frequencies of pELNIH vector in cultured VPC 135 Table 2. Retrotransposition frequencies of human L1 retroelement (pJMIOI) in VPC 135 viii ABSTRACT A primary biosafety issue of retroviral vector-mediated gene therapy is the genetic instability of retroviral vectors. Reverse transcription of vector RNA genome is initiated by viral reverse transcriptase (RT) in a virion particle after infection of a target celi. During reverse transcription, abnormal template switches between vector and occasionally co- packaged helper virus in a virion particle can therefore enable helper virus to regain replication elements from the vector and revert to replication-competent retrovirus (RCR). This research was undertaken to study the origins of RT enzyme activities and test the hypothesis that RT enzyme activities are contributed by both exogenous RT, which is imported by the re-infection of vector virions, and endogenous RT, which is provided by Intracellular vector virion particles. Superinfection of vector in vector producer cells (VPC) can increase the number of integrated vectors in VPC, and is mainly caused by decreased Env-receptor interference, a consequence of helper virus gene inactivation by host DNA methylation at the 5' LTR promoter region. Suppression of helper virus gene expression by DNA methylation also reduces vector production. A chimeric retroviral helper virus combined with picomavirus IRES (internal ribosome entry site) sequence and a selection marker was therefore constructed to eliminate DNA methylated helper virus from cell populations to maintain active gene expression and enhance Env-receptor interference. Packaging cells established by this chimeric helper virus exhibit high titer production
Recommended publications
  • Chapitre Quatre La Spécificité D'hôtes Des Virophages Sputnik
    AIX-MARSEILLE UNIVERSITE FACULTE DE MEDECINE DE MARSEILLE ECOLE DOCTORALE DES SCIENCES DE LA VIE ET DE LA SANTE THESE DE DOCTORAT Présentée par Morgan GAÏA Né le 24 Octobre 1987 à Aubagne, France Pour obtenir le grade de DOCTEUR de l’UNIVERSITE AIX -MARSEILLE SPECIALITE : Pathologie Humaine, Maladies Infectieuses Les virophages de Mimiviridae The Mimiviridae virophages Présentée et publiquement soutenue devant la FACULTE DE MEDECINE de MARSEILLE le 10 décembre 2013 Membres du jury de la thèse : Pr. Bernard La Scola Directeur de thèse Pr. Jean -Marc Rolain Président du jury Pr. Bruno Pozzetto Rapporteur Dr. Hervé Lecoq Rapporteur Faculté de Médecine, 13385 Marseille Cedex 05, France URMITE, UM63, CNRS 7278, IRD 198, Inserm 1095 Directeur : Pr. Didier RAOULT Avant-propos Le format de présentation de cette thèse correspond à une recommandation de la spécialité Maladies Infectieuses et Microbiologie, à l’intérieur du Master des Sciences de la Vie et de la Santé qui dépend de l’Ecole Doctorale des Sciences de la Vie de Marseille. Le candidat est amené à respecter des règles qui lui sont imposées et qui comportent un format de thèse utilisé dans le Nord de l’Europe permettant un meilleur rangement que les thèses traditionnelles. Par ailleurs, la partie introduction et bibliographie est remplacée par une revue envoyée dans un journal afin de permettre une évaluation extérieure de la qualité de la revue et de permettre à l’étudiant de commencer le plus tôt possible une bibliographie exhaustive sur le domaine de cette thèse. Par ailleurs, la thèse est présentée sur article publié, accepté ou soumis associé d’un bref commentaire donnant le sens général du travail.
    [Show full text]
  • Replication-Defective Chimeric Helper Proviruses and Factors Affecting Generation of Competent Virus
    MOLECULAR AND CELLULAR BIOLOGY, May 1987, p. 1797-1806 Vol. 7, No. 5 0270-7306/87/051797-10$02.00/0 Copyright © 1987, American Society for Microbiology Replication-Defective Chimeric Helper Proviruses and Factors Affecting Generation of Competent Virus: Expression of Moloney Murine Leukemia Virus Structural Genes via the Metallothionein Promoter ROBERT A. BOSSELMAN,* ROU-YIN HSU, JOAN BRUSZEWSKI, SYLVIA HU, FRANK MARTIN, AND MARGERY NICOLSON Amgen, Thousand Oaks, California 91320 Received 15 October 1986/Accepted 28 January 1987 Two chimeric helper proviruses were derived from the provirus of the ecotropic Moloney murine leukemia virus by replacing the 5' long terminal repeat and adjacent proviral sequences with the mouse metallothionein I promoter. One of these chimeric proviruses was designed to express the gag-pol genes of the virus, whereas the other was designed to express only the env gene. When transfected into NIH 3T3 cells, these helper proviruses failed to generate competent virus but did express Zn2 -inducible trans-acting viral functions needed to assemble infectious vectors. One helper cell line (clone 32) supported vector assembly at levels comparable to those supported by the Psi-2 and PA317 cell lines transfected with the same vector. Defective proviruses which carry the neomycin phosphotransferase gene and which lack overlapping sequence homology with the 5' end of the chimeric helper proviruses could be transfected into the helper cell line without generation of replication-competent virus. Mass cultures of transfected helper cells produced titers of about 104 G418r CFU/ml, whereas individual clones produced titers between 0 and 2.6 x 104 CFU/ml.
    [Show full text]
  • DNA Recombination Is Sufficient for Retroviral Transduction JODY R
    Proc. Natl. Acad. Sci. USA Vol. 92, pp. 2460-2464, March 1995 Biochemistry DNA recombination is sufficient for retroviral transduction JODY R. SCHWARTZ, Susi DUESBERG, AND PETER H. DUESBERG Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720-3206 Contributed by Peter H. Duesberg, November 28, 1994 ABSTRACT Oncogenic retroviruses carry coding se- quences that are transduced from cellular protooncogenes. Nat- env pOl X ural transduction involves two nonhomologous recombinations and is thus extremely rare. Since transduction has never been reproduced experimentall, its mechanism has been studied in terms oftwoehypotheses: (i) the DNAmodel,which postulates two ___ _-I ____ DNA recombinations, and (ii) the RNA model, which postulates a 5' DNA recombination and a 3' RNA recombination occurring during reverse transcription of viral and protooncogene RNA. proto-onc gene Here we use two viral DNA constructs to test the prediction ofthe DNA model that the 3' DNA recombination is achieved by conventional integration of a retroviral DNA 3' of the chromo- somal protooncogene coding region. For the DNA model to be ga-onc - gag viable, such recombinant viruses must be infectious without the w5 essential tract that precedes the 3' purportedly polypurine (ppt) FIG. 1. The DNA model of retroviral transduction. The model long terminal repeat (LTR) of all retroviruses. Our constructs proposes that the 5' retrovirus/protooncogene junction is achieved by consist ofa ras coding region from Harvey sarcoma virus which nonhomologous recombination between a circular provirus with a is naturally linked at the 5' end to a retroviral LTR and single LTR. Such proviruses are common in virus-infected cells (1).
    [Show full text]
  • The LUCA and Its Complex Virome in Another Recent Synthesis, We Examined the Origins of the Replication and Structural Mart Krupovic , Valerian V
    PERSPECTIVES archaea that form several distinct, seemingly unrelated groups16–18. The LUCA and its complex virome In another recent synthesis, we examined the origins of the replication and structural Mart Krupovic , Valerian V. Dolja and Eugene V. Koonin modules of viruses and posited a ‘chimeric’ scenario of virus evolution19. Under this Abstract | The last universal cellular ancestor (LUCA) is the most recent population model, the replication machineries of each of of organisms from which all cellular life on Earth descends. The reconstruction of the four realms derive from the primordial the genome and phenotype of the LUCA is a major challenge in evolutionary pool of genetic elements, whereas the major biology. Given that all life forms are associated with viruses and/or other mobile virion structural proteins were acquired genetic elements, there is no doubt that the LUCA was a host to viruses. Here, by from cellular hosts at different stages of evolution giving rise to bona fide viruses. projecting back in time using the extant distribution of viruses across the two In this Perspective article, we combine primary domains of life, bacteria and archaea, and tracing the evolutionary this recent work with observations on the histories of some key virus genes, we attempt a reconstruction of the LUCA virome. host ranges of viruses in each of the four Even a conservative version of this reconstruction suggests a remarkably complex realms, along with deeper reconstructions virome that already included the main groups of extant viruses of bacteria and of virus evolution, to tentatively infer archaea. We further present evidence of extensive virus evolution antedating the the composition of the virome of the last universal cellular ancestor (LUCA; also LUCA.
    [Show full text]
  • Viral Envelope Are Controlled by the Helper Virus Used to Activate The
    DETERMINING FACTOR IN THE CAPACITY OF ROUS SARCOMA VIRUS TO INDUCE TUMORS IN MAMMALS* By HIDESABURO HANAFUSA AND TERUKO HANAFUSA COLLMGE DE FRANCE, LABORATOIRE DE MIDECINE EXPARIMENTALE, PARIS Communidated by Ahdre Lwoff, January 24, 1966 Since Zilber and Kriukoval and Svet-Moldavsky' demonstrated that some strains of Rous sarcoma virus (RSV) are capable of inducing hemorrhagic cysts or sarcomas in newborn rats, numerous attempts have been made to induce tumors by RSVin various species of mammals.3-9 One of the remarkable aspects revealed by these investigations is the strain differences in RSV for this capacity.6-9 Certain strains, such as the Schmidt-Ruppin strain, are active, while others, such as the Bryan strain, are generally inactive in mammals. The cause of such strain differ- ences has not been elucidated. Our previous studies have shown that the Bryan high-titer strain of RSV is a defective virus which cannot reproduce without the help of any one of the avian leukosis viruses.'0 The defectiveness derives from the inability of this strain of RSV to induce the synthesis of its own viral envelope."I An essential role played by the helper virus is to provide the envelope to the RSV genome, whose replica- tion occurs in the infected cells without the aid of helper virus. Thus, several properties of RSV which presumably depend in some way on the character of the viral envelope are controlled by the helper virus used to activate the RSV.11-13 These properties include the antigenicity, the sensitivity to the interference induced by the helper virus, and the host range among genetically different chick embryos.
    [Show full text]
  • Satellite RNA-Mediated Resistance to Turnip Crinkle Virus in Arabidopsis Lnvolves a Reduction in Virus Movement
    The Plant Cell, Vol. 9, 2051-2063, November 1997 O 1997 American Society of Plant Physiologists Satellite RNA-Mediated Resistance to Turnip Crinkle Virus in Arabidopsis lnvolves a Reduction in Virus Movement Qingzhong Kong, Jianlong Wang, and Anne E. Simon’ Department of Biochemistry and Molecular Biology and Program in Molecular and Cellular Biology, University of Massachusetts, Amherst, Massachusetts O1 003-4505 Satellite RNAs (sat-RNAs) are parasites of viruses that can mediate resistance to the helper virus. We previously showed that a sat-RNA (sat-RNA C) of turnip crinkle virus (TCV), which normally intensifies symptoms of TCV, is able to attenuate symptoms when TCV contains the coat protein (CP) of cardamine chlorotic fleck virus (TCV-CPccw).We have now determined that sat-RNA C also attenuates symptoms of TCV containing an alteration in the initiating AUG of the CP open reading frame (TCV-CPm). TCV-CPm, which is able to move systemically in both the TCV-susceptible ecotype Columbia (Col-O) and the TCV-resistant ecotype Dijon (Di-O), produced a reduced level of CP and no detectable virions in infected plants. Sat-RNA C reduced the accumulation of TCV-CPm by <25% in protoplasts while reducing the level of TCV-CPm by 90 to 100% in uninoculated leaves of COLO and Di-O. Our results suggest that in the presence of a re- duced level of a possibly altered CP, sat-RNA C reduces virus long-distance movement in a manner that is independent of the salicylic acid-dependent defense pathway. INTRODUCTION Plants exhibit different types of resistance to plant viruses, on virus association for replication and spread in plants.
    [Show full text]
  • Effects of Retroviruses on Host Genome Function
    ANRV361-GE42-20 ARI 1 August 2008 18:2 V I E E W R S I E N C N A D V A Effects of Retroviruses on Host Genome Function Patric Jern and John M. Coffin Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts 02111; email: [email protected], John.Coffi[email protected] Annu. Rev. Genet. 2008. 42:20.1–20.23 Key Words The Annual Review of Genetics is online at Human Endogenous Retrovirus, LTR, transcription, recombination, genet.annualreviews.org methylation This article’s doi: 10.1146/annurev.genet.42.110807.091501 Abstract Copyright c 2008 by Annual Reviews. For millions of years, retroviral infections have challenged vertebrates, All rights reserved occasionally leading to germline integration and inheritance as ERVs, 0066-4197/08/1201-0001$20.00 genetic parasites whose remnants today constitute some 7% to 8% of the human genome. Although they have had significant evolutionary side effects, it is useful to view ERVs as fossil representatives of retro- viruses extant at the time of their insertion into the germline, not as direct players in the evolutionary process itself. Expression of particu- lar ERVs is associated with several positive physiological functions as well as certain diseases, although their roles in human disease as etio- logical agents, possible contributing factors, or disease markers—well demonstrated in animal models—remain to be established. Here we discuss ERV contributions to host genome structure and function, in- cluding their ability to mediate recombination, and physiological effects on the host transcriptome resulting from their integration, expression, and other events.
    [Show full text]
  • Phagemid-Based Method of Producing Filamentous Bacteriophage Particles Displaying Antibody Molecules and the Corresponding Bacteriophage Particles
    Europäisches Patentamt *EP001433846A2* (19) European Patent Office Office européen des brevets (11) EP 1 433 846 A2 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.7: C12N 15/10, C07K 16/00, 30.06.2004 Bulletin 2004/27 C12N 15/62, C12N 7/00, C12N 15/73 (21) Application number: 04005419.9 (22) Date of filing: 10.07.1991 (84) Designated Contracting States: • Griffiths, Andrew David AT BE CH DE DK ES FR GB GR IT LI LU NL SE Cambridge CB1 4AY (GB) • Jackson, Ronald Henry (30) Priority: 10.07.1990 GB 9015198 Cambridge CB1 2NU (GB) 19.10.1990 GB 9022845 • Holliger, Kaspar Philipp 12.11.1990 GB 9024503 Cambridge CB1 4HT (GB) 06.03.1991 GB 9104744 • Marks, James David 15.05.1991 GB 9110549 Kensington, CA 94707-1310 (US) • Clackson, Timothy Piers (62) Document number(s) of the earlier application(s) in Somerville, MA 02143 (US) accordance with Art. 76 EPC: • Chiswell, David John 97120149.6 / 0 844 306 Buckingham MK18 2LD (GB) 96112510.1 / 0 774 511 • Winter, Gregory Paul Cambridge CB2 1TQ (GB) (71) Applicants: • Bonnert, Timothy Peter • Cambridge Antibody Technology LTD Seattle, WA 98102 (US) Cambridge CB1 6GH (GB) • Medical Research Council (74) Representative: Walton, Seán Malcolm et al London W1B 1AL (GB) Mewburn Ellis LLP York House, (72) Inventors: 23 Kingsway • McCafferty, John London WC2B 6HP (GB) Babraham CB2 4AP (GB) • Pope, Anthony Richard Remarks: Cambridge CB1 2LW (GB) This application was filed on 08 - 03 - 2004 as a • Johnson, Kevin Stuart divisional application to the application mentioned Highfields, Cambridge CB3 7NY (GB) under INID code 62.
    [Show full text]
  • Proviruses with Long-Term Stable Expression Accumulate In
    viruses Article Proviruses with Long-Term Stable Expression Accumulate in Transcriptionally Active Chromatin Close to the Gene Regulatory Elements: Comparison of ASLV-, HIV- and MLV-Derived Vectors Dalibor Miklík 1,2, Filip Šenigl 1 and Jiˇrí Hejnar 1,* 1 Institute of Molecular Genetics, Czech Academy of Sciences, Videnska 1083, CZ-14220 Prague 4, Czech Republic; [email protected] (D.M.); [email protected] (F.S.) 2 Faculty of Science, Charles University, Albertov 6, CZ-12843 Prague 2, Czech Republic * Correspondence: [email protected] Received: 29 January 2018; Accepted: 6 March 2018; Published: 8 March 2018 Abstract: Individual groups of retroviruses and retroviral vectors differ in their integration site preference and interaction with the host genome. Hence, immediately after infection genome-wide distribution of integrated proviruses is non-random. During long-term in vitro or persistent in vivo infection, the genomic position and chromatin environment of the provirus affects its transcriptional activity. Thus, a selection of long-term stably expressed proviruses and elimination of proviruses, which have been gradually silenced by epigenetic mechanisms, helps in the identification of genomic compartments permissive for proviral transcription. We compare here the extent and time course of provirus silencing in single cell clones of the K562 human myeloid lymphoblastoma cell line that have been infected with retroviral reporter vectors derived from avian sarcoma/leukosis virus (ASLV), human immunodeficiency virus type 1 (HIV) and murine leukaemia virus (MLV). While MLV proviruses remain transcriptionally active, ASLV proviruses are prone to rapid silencing. The HIV provirus displays gradual silencing only after an extended time period in culture.
    [Show full text]
  • Helper-Dependent Adenoviral Vectors
    ndrom Sy es tic & e G n e e n G e f T o Rosewell, J Genet Syndr Gene Ther 2011, S:5 Journal of Genetic Syndromes h l e a r n a r p DOI: 10.4172/2157-7412.S5-001 u y o J & Gene Therapy ISSN: 2157-7412 Review Article Open Access Helper-Dependent Adenoviral Vectors Amanda Rosewell, Francesco Vetrini, and Philip Ng* Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030 USA Abstract Helper-dependent adenoviral vectors are devoid of all viral coding sequences, possess a large cloning capacity, and can efficiently transduce a wide variety of cell types from various species independent of the cell cycle to mediate long-term transgene expression without chronic toxicity. These non-integrating vectors hold tremendous potential for a variety of gene transfer and gene therapy applications. Here, we review the production technologies, applications, obstacles to clinical translation and their potential resolutions, and the future challenges and unanswered questions regarding this promising gene transfer technology. Introduction DNA polymerase and terminal protein precursor (pTP). The E3 region, which is dispensable for virus growth in cell culture, encodes at least Helper-dependent adenoviral vectors (HDAd) are deleted of all seven proteins most of which are involved in host immune evasion. The viral coding sequences, can efficiently transduce a wide variety of cell E4 region encodes at least six proteins, some functioning to facilitate types from various species independent of the cell cycle, and can result in DNA replication, enhance late gene expression and decrease host long-term transgene expression.
    [Show full text]
  • Frequent Provirus Insertional Mutagenesis of Notchl in Thymomas of MMTVD/Myc Transgenic Mice Suggests a Collaboration of C-Myc and Notctil for Oncogenesis
    Downloaded from genesdev.cshlp.org on September 24, 2021 - Published by Cold Spring Harbor Laboratory Press Frequent provirus insertional mutagenesis of Notchl in thymomas of MMTVD/myc transgenic mice suggests a collaboration of c-myc and Notctil for oncogenesis Luc Girard, l Zaher Hanna, 1,2 Normand Beaulieu, 1 Caroline D. Hoemann, 1 Carole Simard, 1 Christine A. Kozak, 3 and Paul Jolicoeur 1'4'5"6 1Laboratory of Molecular Biology, Clinical Research Institute of Montr4al, Montr4al, Qu~bec, Canada H2W 1R7; 2D4partement de Mddecine et de 4 Microbiologie et d'Immunologie, Universit~ de Montr4al, Montreal, Quebec, Canada H3J 3J7; 3National Institute of Allergy and Infectious Diseases (NIAIDI, National Institutes of Health, Bethesda, Maryland 20892, USA; SDepartment of Experimental Medicine, McGill University, Montr4al, Quebec, Canada, H3G-1A4 The MMTVD/myc transgenic mice spontaneously develop oligoclonal CD4+CD8 + T-ceU tumors. We used provirus insertional mutagenesis in these mice to identify putative collaborators of c-myc. We found that Notchl was mutated in a high proportion (52%) of these tumors. Proviruses were inserted upstream of the exon coding for the transmembrane domain and in both transcriptional orientations. These mutations led to high expression of truncated Notchl RNAs and proteins (86-110 kD). In addition, many Notchl-rearranged tumors showed elevated levels of full-length Notchl transcripts, whereas nearly all showed increased levels of full-length (330-kD) or close to full-length (280-kD) Notchl proteins. The 5' end of the truncated RNAs were determined for some tumors by use of RT-PCR and 5' RACE techniques. Depending on the orientation of the proviruses, viral LTR or cryptic promoters appeared to be utilized, and coding potential began in most cases in the transmembrane domain.
    [Show full text]
  • Antibody Discovery for Development of a Serotyping Dengue Virus NS1 Capture Assay
    Antibody Discovery for Development of a Serotyping Dengue Virus NS1 Capture Assay Kebaneilwe Lebani Master of Biotechnology (Advanced) A thesis submitted for the degree of Doctor of Philosophy at The University of Queensland in 2014 Australian Institute for Bioengineering and Nanotechnology ABSTRACT Dengue virus (DENV) infections are a significant public health burden in tropical and sub-tropical regions of the world. Infections are caused by four different but antigenically related viruses which result in four DENV serotypes. The multifaceted nature of DENV pathogenesis hinders the sensitivity of assays designed for the diagnosis of infection. Different markers can be optimally detected at different stages of infection. Of particular clinical importance is the identification of acute viremia during the febrile phase of infection which is pivotal for management of infection. Non-structural protein 1 (NS1) has been identified as a good early surrogate marker of infection with possible applications in epidemiological surveillance and the development of blood screening assays. This contribution is towards using serotype-specificity to achieve specific and more sensitive diagnostic detection of DENV NS1. The general aim of this work is to isolate immune-reagents that can be used to develop an assay with improved sensitivity of DENV NS1 detection in a diagnostic setting. In this work, we sought to isolate serotype-specific antibodies that discern discreet antigenic differences in NS1 from each DENV serotype. Additionally, we also sought to isolate a pairing antibody that recognises NS1 from all four DENV serotypes (pan-reactive) for tandem capture of the DENV NS1. To achieve this, three naive, immunoglobulin gene libraries (a VH domain, a scFv and a Fab library) were interrogated for binders to recombinant NS1 antigen from all four DENV serotypes using phage display technology and various biopanning approaches.
    [Show full text]